Indegene Ltd (INDGN) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 10039241,
    "name": "Indegene",
    "stock_name": "Indegene",
    "full_name": "Indegene Ltd",
    "name_url": "stocks-analysis/indegene",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "519.00",
    "chg": 2.7,
    "chgp": "0.52%",
    "dir": 1,
    "prev_price": "516.30",
    "mcapval": "12,503.34 Cr",
    "mcap": "Small Cap",
    "scripcode": 544172,
    "symbol": "INDGN",
    "ind_name": "Healthcare Services",
    "ind_code": 57,
    "indexname": "India SENSEX",
    "isin": "INE065X01017",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "1.07 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/indegene-10039241-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Indegene Ltd’s Mixed Week: -0.85% Price Change Amid Technical Shifts and Financial Upgrades",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indegene-ltds-mixed-week--085-price-change-amid-technical-shifts-and-financial-upgrades-3982658",
        "imagepath": "",
        "date": "2026-05-09 10:02:58",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>4 May:</strong> Intraday high with 7.28% surge to Rs.533.80</p>\n                    <p><strong>5 May:</strong> Technical momentum shifts amid mixed signals, closing at Rs.544.50 (+1.93%)</p>\n                    <p><strong>6 May:</strong> MarketsMOJO upgrades rating to Hold amid mixed financials</p>\n                    <p><strong>8 May:</strong> Week closes at Rs.529.65 (-0.28%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.534.20</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.52..."
      },
      {
        "title": "Indegene Ltd Surges 7.28% to Day's High of Rs 533.8 — Outperforms Healthcare Sector by 7.59 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indegene-ltd-hits-intraday-high-with-728-surge-on-4-may-2026-3974242",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/IndegeneLtd_priceRelatedfactors_3974242.png",
        "date": "2026-05-04 15:31:05",
        "description": "The Sensex advanced 0.52% on 4 May 2026, yet Indegene Ltd outpaced the broader market with a 7.28% gain, touching an intraday high of Rs 533.8. This 7.59-percentage-point outperformance over its Healthcare Services sector peers signals a distinctly stock-specific rally rather than a market-wide lift."
      },
      {
        "title": "Are Indegene Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-indegene-ltd-latest-results-good-or-bad-3970757",
        "imagepath": "",
        "date": "2026-04-30 19:17:54",
        "description": "Indegene Ltd's latest financial results for Q4 FY26 present a complex picture characterized by strong revenue growth juxtaposed with significant profitability challenges. The company reported a revenue of ₹1,003.40 crores, marking a year-on-year growth of 32.80% and a sequential increase of 6.51%. This achievement reflects robust demand and operational momentum, as it is the first time Indegene has surpassed the ₹1,000 crore mark in a single quarter.\n\nHowever, the profitability metrics reveal a stark decline. The net profit for the quarter stood at ₹79.70 crores, which represents a year-on-year decrease of 32.23% and a sequential drop of 22.55%. The profit after tax (PAT) margin contracted sharply to 7.94%, down from 15.56% in the same quarter last year, indicating significant challenges in converting revenue growth into profit. Additionally, the operating margin, excluding other income, fell to 16.30% from..."
      },
      {
        "title": "Indegene Ltd Reports Flat Quarterly Financial Performance Amid Margin Pressures",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indegene-ltd-reports-flat-quarterly-financial-performance-amid-margin-pressures-3970178",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IndegeneLtd_fintrenddot_3970178.png",
        "date": "2026-04-30 11:00:08",
        "description": "Indegene Ltd, a healthcare services small-cap, posted a mixed set of results for the quarter ended March 2026, with record net sales and PBDIT overshadowed by a notable decline in net profit and earnings per share. The company’s financial trend has shifted from positive to flat, prompting a downgrade in its Mojo Grade from Hold to Sell as investors weigh the implications of margin pressures and subdued bottom-line growth."
      },
      {
        "title": "Indegene Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indegene-ltd-is-rated-hold-by-marketsmojo-3962086",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IndegeneLtd_mojoScore_3962086.png",
        "date": "2026-04-25 10:10:36",
        "description": "Indegene Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 April 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "When is the next results date for Indegene Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-indegene-ltd-3958126",
        "imagepath": "",
        "date": "2026-04-22 23:16:13",
        "description": "Indegene Ltd is scheduled to declare its results on 29 April 2026...."
      },
      {
        "title": "Indegene Ltd Upgraded to Hold by MarketsMOJO on Improved Technicals and Financial Metrics",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indegene-ltd-upgraded-to-hold-by-marketsmojo-on-improved-technicals-and-financial-metrics-3945314",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IndegeneLtd_mojoScore_3945314.png",
        "date": "2026-04-14 08:50:39",
        "description": "Indegene Ltd, a healthcare services company, has seen its investment rating upgraded from Sell to Hold as of 13 April 2026, reflecting a nuanced improvement across multiple evaluation parameters including quality, valuation, financial trends, and technical indicators. This article delves into the factors driving this change and what it means for investors navigating the healthcare services sector."
      },
      {
        "title": "Indegene Ltd Gains 4.17% This Week: Technical Shifts and Downgrade Impact",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indegene-ltd-gains-417-this-week-technical-shifts-and-downgrade-impact-3942231",
        "imagepath": "",
        "date": "2026-04-11 10:01:46",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>6 Apr:</strong> Week opens at Rs.470.45</p>\n                    <p><strong>7 Apr:</strong> Downgrade to Sell amid technical weakness and growth concerns</p>\n                    <p><strong>8 Apr:</strong> Technical momentum shifts to bearish; stock rebounds +3.88%</p>\n                    <p><strong>9 Apr:</strong> Mixed technical signals as stock gains +1.55%</p>\n                    <p><strong>10 Apr:</strong> Week closes at Rs.490.05, marginally down -0.09% on day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.470.45</div></div>\n                    <div..."
      },
      {
        "title": "Indegene Ltd Downgraded to Sell Amid Technical Weakness and Growth Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indegene-ltd-downgraded-to-sell-amid-technical-weakness-and-growth-concerns-3936634",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IndegeneLtd_mojoScore_3936634.png",
        "date": "2026-04-08 08:30:19",
        "description": "Indegene Ltd, a healthcare services company, has seen its investment rating downgraded from Hold to Sell as of 7 April 2026, driven primarily by deteriorating technical indicators and concerns over its long-term growth prospects despite recent positive quarterly financial results."
      }
    ],
    "total": 15,
    "sid": "10039241",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/indegene-10039241"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "11-Jun-2026",
      "details": "Intimation of Investors / Analysts Meeting",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "03-Jun-2026",
      "details": "Intimation of Investor Meeting",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
      "datetime": "28-May-2026",
      "details": "Revised Investor Presentation",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Indegene Ltd has declared <strong>100%</strong> dividend, ex-date: 13 Jun 25",
          "dt": "2025-06-13",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Indegene Ltd’s Mixed Week: -0.85% Price Change Amid Technical Shifts and Financial Upgrades

2026-05-09 10:02:58

Key Events This Week 4 May: Intraday high with 7.28% surge to Rs.533.80 5 May: Technical momentum shifts amid mixed signals, closing at Rs.544.50 (+1.93%) 6 May: MarketsMOJO upgrades rating to Hold amid mixed financials 8 May: Week closes at Rs.529.65 (-0.28%) Week OpenRs.534.20 Week CloseRs.52...

Indegene Ltd Surges 7.28% to Day's High of Rs 533.8 — Outperforms Healthcare Sector by 7.59 Percentage Points

2026-05-04 15:31:05

The Sensex advanced 0.52% on 4 May 2026, yet Indegene Ltd outpaced the broader market with a 7.28% gain, touching an intraday high of Rs 533.8. This 7.59-percentage-point outperformance over its Healthcare Services sector peers signals a distinctly stock-specific rally rather than a market-wide lift.

Are Indegene Ltd latest results good or bad?

2026-04-30 19:17:54

Indegene Ltd's latest financial results for Q4 FY26 present a complex picture characterized by strong revenue growth juxtaposed with significant profitability challenges. The company reported a revenue of ₹1,003.40 crores, marking a year-on-year growth of 32.80% and a sequential increase of 6.51%. This achievement reflects robust demand and operational momentum, as it is the first time Indegene has surpassed the ₹1,000 crore mark in a single quarter. However, the profitability metrics reveal a stark decline. The net profit for the quarter stood at ₹79.70 crores, which represents a year-on-year decrease of 32.23% and a sequential drop of 22.55%. The profit after tax (PAT) margin contracted sharply to 7.94%, down from 15.56% in the same quarter last year, indicating significant challenges in converting revenue growth into profit. Additionally, the operating margin, excluding other income, fell to 16.30% from...

Indegene Ltd Reports Flat Quarterly Financial Performance Amid Margin Pressures

2026-04-30 11:00:08

Indegene Ltd, a healthcare services small-cap, posted a mixed set of results for the quarter ended March 2026, with record net sales and PBDIT overshadowed by a notable decline in net profit and earnings per share. The company’s financial trend has shifted from positive to flat, prompting a downgrade in its Mojo Grade from Hold to Sell as investors weigh the implications of margin pressures and subdued bottom-line growth.

Indegene Ltd is Rated Hold by MarketsMOJO

2026-04-25 10:10:36

Indegene Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 April 2026, providing investors with the latest insights into the company’s performance and outlook.

When is the next results date for Indegene Ltd?

2026-04-22 23:16:13

Indegene Ltd is scheduled to declare its results on 29 April 2026....

Indegene Ltd Upgraded to Hold by MarketsMOJO on Improved Technicals and Financial Metrics

2026-04-14 08:50:39

Indegene Ltd, a healthcare services company, has seen its investment rating upgraded from Sell to Hold as of 13 April 2026, reflecting a nuanced improvement across multiple evaluation parameters including quality, valuation, financial trends, and technical indicators. This article delves into the factors driving this change and what it means for investors navigating the healthcare services sector.

Indegene Ltd Gains 4.17% This Week: Technical Shifts and Downgrade Impact

2026-04-11 10:01:46

Key Events This Week 6 Apr: Week opens at Rs.470.45 7 Apr: Downgrade to Sell amid technical weakness and growth concerns 8 Apr: Technical momentum shifts to bearish; stock rebounds +3.88% 9 Apr: Mixed technical signals as stock gains +1.55% 10 Apr: Week closes at Rs.490.05, marginally down -0.09% on day Week OpenRs.470.45 <div...

Indegene Ltd Downgraded to Sell Amid Technical Weakness and Growth Concerns

2026-04-08 08:30:19

Indegene Ltd, a healthcare services company, has seen its investment rating downgraded from Hold to Sell as of 7 April 2026, driven primarily by deteriorating technical indicators and concerns over its long-term growth prospects despite recent positive quarterly financial results.

View All News